Institut Paoli Calmettes Prostate Cancer Database
NCT02869594 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 10000
Last updated 2016-08-17
Summary
Database of Institut Paoli-Calmettes patients diagnosed with prostate cancer
Conditions
- Prostatic Neoplasms
Interventions
- OTHER
-
Data collection
Sponsors & Collaborators
-
Institut Paoli-Calmettes
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 95 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-01-31
- Primary Completion
- 2030-01-31
- Completion
- 2030-12-31
Countries
- France
Study Locations
More Related Trials
-
PRO-STATE:Search for a Protein Profile Corresponding to Fast-developing Lesions and Characterization of Implicated Proteins in Prostate Carcinoma
NCT00427817 ·Status: COMPLETED
-
Assessment of Prostate MRI Before Prostate Biopsies
NCT02485379 ·Status: COMPLETED ·Phase: NA
-
Multicentric Evaluation of the True Negative Predictive Value of Multiparametric MRI for the Detection of Prostate Cancer Using Cystoprostatectomy Specimen as Reference
NCT03960112 ·Status: UNKNOWN ·Phase: NA
-
A Study of Participants With Advanced Prostate Cancer in Canada
NCT03501173 ·Status: COMPLETED
-
The IMPACT Study - Identification of Men With a Genetic Predisposition to ProstAte Cancer
NCT00261456 ·Status: ACTIVE_NOT_RECRUITING
-
DRG Mutations in Prostate Cancer: a Guiding Light for Enhanced Screening and Personalised Therapy
NCT07265414 ·Status: ACTIVE_NOT_RECRUITING
-
Detection of Micrometastases in Lymph Nodes of Patients With Prostate Cancer
NCT01615965 ·Status: UNKNOWN ·Phase: NA
-
Individual Phenotype Analysis in Patients With Castration-Resistant Prostate Cancer With CellSearch® and Flow Cytometry
NCT02282644 ·Status: COMPLETED ·Phase: NA
-
Prostate Cancer Screening in Men With Germline BRCA2 Mutations
NCT02154672 ·Status: COMPLETED
-
Metastasis-directed Therapy in Oligoprogressive Castration-refractory Prostate Cancer
NCT06585007 ·Status: RECRUITING ·Phase: PHASE3
-
Prostate Cancer Antigen 3 (PCA-3) Gene Project
NCT01177436 ·Status: COMPLETED ·Phase: NA
-
Detecting Metastases by PyL PET/CT in Subjects Starting Enzalutamide for Untreated Castration Resistant Prostate Cancer.
NCT04655365 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Utility of Hyperpolarized 13C-pyruvate Metabolic Magnetic Resonance Imaging
NCT04698564 ·Status: TERMINATED ·Phase: PHASE2
-
68Ga-XACP3 PET/CT in Prostate Cancer
NCT07242014 ·Status: RECRUITING ·Phase: NA
-
PROMISE PET Registry on PSMA-PET and Outcome in Prostate Cancer
NCT06320223 ·Status: RECRUITING
-
Identify Genes/Pathways Responsible for Progression From Low Risk to Higher Risk Prostate Cancer
NCT03789253 ·Status: RECRUITING
-
Immuno-molecular Approaches for Non-invasive Diagnosis of Prostate Cancer
NCT04702633 ·Status: COMPLETED
-
Primary Care-Based Follow-up of Cancer Survivors of the Prostate and Kidney
NCT06214000 ·Status: COMPLETED
-
PROMISE Registry: A Prostate Cancer Registry of Outcomes and Germline Mutations for Improved Survival and Treatment Effectiveness
NCT04995198 ·Status: RECRUITING
-
Diagnostic Performance of PSMA PET/CT for Pre-operative Lymph Node Assessment in Intermediate and High-risk Non-metastasic Prostate Cancer (PREOP-PSMA ).
NCT04745871 ·Status: TERMINATED ·Phase: NA
-
Clinical and Dosimetric Study of Patients Treated With 177Lu-PSMA-617 for Prostate Cancer.
NCT06700057 ·Status: RECRUITING
-
Place of 68Ga-PSMA-11 PET-CT in the Therapeutic Decision at the End of the Initial Staging for High Risk Prostate Cancer Patients
NCT03344822 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Choline-PET for Evaluating the Incidence of Nodal Metastases Among Newly Diagnosed Patients of Prostate Cancer
NCT01769950 ·Status: UNKNOWN ·Phase: NA
-
Early Detection of Prostate Cancer
NCT04556916 ·Status: RECRUITING ·Phase: NA
-
Prostate Biopsies With Target Lesion on MRI
NCT04692207 ·Status: COMPLETED